(1R,2R,3S,4R,5S)-4-[6-[[(R)-cyclobutyl(cyclopropyl)methyl]amino]-2-iodopurin-9-yl]-1-(hydroxymethyl)bicyclo[3.1.0]hexane-2,3-diol

InChIKey	`NRMMOPXCAHUSCA-OHTVDBCQSA-N`
Compound Name	(1R,2R,3S,4R,5S)-4-[6-[[(R)-cyclobutyl(cyclopropyl)methyl]amino]-2-iodopurin-9-yl]-1-(hydroxymethyl)bicyclo[3.1.0]hexane-2,3-diol
Canonical SMILES	`OC[C@@]12C[C@@H]1[C@@H](n1cnc3c(N[C@@H](C4CCC4)C4CC4)nc(I)nc31)[C@H](O)[C@@H]2O`
Clinical Status	Data-mined Candidate
Targets (Human+Pathogen)	3
Pfam Stratification	Homologous
Avg pChEMBL	7.07
Source	ChEMBL

2D Structure

Activity Profile

Target	Gene	Organism	Category	Pfam	pChEMBL	Type	Source
P41595	HTR2B	Homo sapiens	Human	PF00001	7.8	Ki	ChEMBL
P30542	ADORA1	Homo sapiens	Human	PF00001	7.2	Ki	ChEMBL
P28335	HTR2C	Homo sapiens	Human	PF00001	6.3	Ki	ChEMBL